Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses

Fragility Fractures Requiring Special Consideration

(2014) Christian Kammerlander et al.   CLINICS IN GERIATRIC MEDICINE

The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine

(2014) Nicole C Wright et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Clinician’s Guide to Prevention and Treatment of Osteoporosis

(2014) F. Cosman et al.   OSTEOPOROSIS INTERNATIONAL

Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis

(2013) Toshitaka Nakamura et al.   CALCIFIED TISSUE INTERNATIONAL

Osteoporosis in older persons: current pharmacotherapy and future directions

(2013) Gustavo Duque   EXPERT OPINION ON PHARMACOTHERAPY

Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women

(2013) Hua Bai et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Graphical Tools for Network Meta-Analysis in STATA

(2013) Anna Chaimani et al.   PLoS One

A review of minodronic acid hydrate for the treatment of osteoporosis

(2013) Shinji Tanishima et al.   Clinical Interventions in Aging

Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

(2012) Michael McClung et al.   AMERICAN JOURNAL OF MEDICINE

Review of radiological scoring methods of osteoporotic vertebral fractures for clinical and research settings

(2012) Ling Oei et al.   EUROPEAN RADIOLOGY

Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews

(2012) Rebecca M Turner et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

(2012) Steven Boonen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies

(2012) J. P. T. Higgins et al.   Research Synthesis Methods

Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression

(2012) Ian R. White et al.   Research Synthesis Methods

Bisphosphonates for post-menopausal osteoporosis: are they all the same?

(2011) R. Rizzoli   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Efficacy and safety of monthly ibandronate in men with low bone density

(2010) Eric S. Orwoll et al.   BONE

The Efficacy of Bisphosphonates in the Prevention of Vertebral, Hip, and Nonvertebral-Nonhip Fractures in Osteoporosis: A Network Meta-Analysis

(2010) Jeroen P. Jansen et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies

(2009) Jeroen P. Jansen et al.   CURRENT MEDICAL RESEARCH AND OPINION

A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered

(2009) Georgia Salanti et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International

(2008) D. M. Reid et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study

(2008) Steven Boonen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Antiresorptive Effects of a Single Dose of Zoledronate Persist for Two Years: A Randomized, Placebo-Controlled Trial in Osteopenic Postmenopausal Women

(2008) Andrew Grey et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study

(2008) T. Matsumoto et al.   OSTEOPOROSIS INTERNATIONAL